Introduction {#sec1}
============

Recently, substantial progress has been made to elicit organogenesis in 3D culture ([@bib1; @bib17; @bib23; @bib37; @bib39]). In the neural lineage, embryoid body-like aggregates were used to generate structures of the cerebral cortex, the pituitary gland, and the retina, three anterior regions of the neuraxis ([@bib13; @bib14; @bib25; @bib40]). In the reconstituted cortex or retina, embryonic stem cell (ESC) differentiation led to the self-formation of layered structures containing different types of neurons. So far, self-organization in CNS organoids has been achieved using large, preaggregated cultures consisting of 3,000 to 10,000 cells, a condition where local inhomogeneities arise to promote complex tissue formation. The contribution of nonneural cells secreting signaling molecules could also not be excluded. Spinal cord level cells have already been induced from mouse embryonic stem cells (mESCs) in the context of complex embryoid bodies that contained a mixture of cells from different germ layers ([@bib30; @bib44]).

Here, we induce neural tube formation from mESCs by direct embedding of single-cell suspensions under neural induction conditions. Untreated, these 3D neuroepithelia have dorsal identity but respond to the ventralizing influence of sonic hedgehog (SHH). Upon retinoic acid (RA) addition, they are posteriorized to cervical levels but also spontaneously form a localized floor plate (FP). This FP elicits full dorsal/ventral (DV) patterning, including motor neurons (MNs) and ventral and dorsal interneurons. Such a system will have numerous uses for studying the mechanism of morphogen action in a 3D environment, as well providing a source of patterned spinal cord tissue.

Results {#sec2}
=======

3D Differentiation of mESCs into Polarized Neuroepithelial Cysts {#sec2.1}
----------------------------------------------------------------

We sought to generate a 3D culture system for neural progenitors that reproduces the growth and patterning of the embryonic spinal cord. Single cell suspensions of mouse ESCs from three ESC lines (R1, the SOX1::GFP reporter cell line 46C \[[@bib2]\] and IB10) were embedded in a 3D Matrigel matrix and differentiated along the neural lineage in N2B27 medium ([Figure 1](#fig1){ref-type="fig"}A). With all three cell lines in the presence or absence of Noggin, we obtained spherical- to ellipsoid-shaped structures that possessed a single lumen ([Figure 1](#fig1){ref-type="fig"}B) and reached similar though not identical sizes ([Figure S1](#app2){ref-type="sec"}A available online). The presence of a single lumen makes these structures similar to epithelial cysts as previously described for kidney epithelial cells ([@bib28; @bib45]) and distinguishes them from embryoid bodies or floating aggregates ([@bib13; @bib15; @bib21]), so we refer to our structures as neuroepithelial cysts.

Confocal analysis of immunostained cysts revealed the hallmarks of early neuroepithelial tissue, including apical-basal polarity reflected by apical localization of PROMININ-1, ZO-1, and N-CADHERIN ([Figures 1](#fig1){ref-type="fig"}C, 1D, 1G, and [S1B--S1E](#app2){ref-type="sec"}). Second, the neural stem cell markers NESTIN and MUSASHI ([Figures 1](#fig1){ref-type="fig"}E and 1F) were expressed uniformly. Third, the cells underwent interkinetic nuclear migration reflected by apically localized phospho-histone H3^+^ (pH3^+^) mitotic figures and basally localized S-phase nuclei ([Figure 1](#fig1){ref-type="fig"}H). Electron microscopy revealed large apical membrane surfaces with microvilli and primary cilia, midbodies, and tight junctions, similar to the ultrastructure of the E8 murine embryonic neural tube ([Figures 1](#fig1){ref-type="fig"}I and 1J).

SOX1 expression was used to quantify the percentage of cysts with neuroepithelial identity. On day 5.5, 43.8% ± 16.8% and on day 7 81% ± 4.2% of 46C cysts expressed GFP ([Figure 1](#fig1){ref-type="fig"}K). To exclude that the increase in the proportion of SOX1::GFP^+^ cysts was due to massive cell death, we followed cyst formation and SOX1 expression in live cultures ([Figure S2](#app2){ref-type="sec"}A). A stable number of cysts differentiated over time without significant cell death. Immunostaining showed that many cysts already started to express SOX1::GFP by day 4 ([Figure S2](#app2){ref-type="sec"}B). R1 ESCs formed a similar percentage of SOX1^+^ cysts by day 6 ([Figure S1](#app2){ref-type="sec"}F).

We next investigated neuronal differentiation. Early neural cysts (5--6 days) were composed solely of SOX1^+^ cells ([Figures 1](#fig1){ref-type="fig"}G and [S1](#app2){ref-type="sec"}B), but around day 7 to day 8, neurons started to grow out basolaterally as detected by NeuN, βIII TUBULIN, and MAP2a ([Figures 1](#fig1){ref-type="fig"}L--1N and [S1](#app2){ref-type="sec"}G). At day 9, R1 cysts typically consisted of six layers of pseudostratified progenitors and up to four neuronal cell layers.

Neuroepithelial Cysts Can Initiate Clonally and Show Progressive Expression of Early Developmental Markers {#sec2.2}
----------------------------------------------------------------------------------------------------------

Time-lapse microscopy was used to determine whether cysts can form from single cells. [Movie S1](#mmc2){ref-type="supplementary-material"} and the associated panels ([Figure 2](#fig2){ref-type="fig"}A) show that a single ESC remained in a stable position and clonally formed a neuroepithelial cyst. Whole-mount immunostainings and confocal imaging of PROMININ-1 after time-lapse acquisition showed that clonal neuroepithelial cysts possessed single lumina ([Figure 2](#fig2){ref-type="fig"}A). The vast majority of the initial ESC suspension represented single cells, but a minority of two- to three-cell clusters also gave rise to cysts. In addition, filming and the presence of bilobed cysts indicated that closely juxtaposed cysts can fuse at a frequency of 5% or less. We excluded such bilobed cysts from the quantitative analysis.

We next examined the onset of neural commitment using developmental markers. Immunostainings for E- and N-CADHERIN showed that on day 2 and day 4 cysts already harbor a visible lumen and express E-CADHERIN but not yet N-CADHERIN. Robust N-CADHERIN and SOX1 and loss of E-CADHERIN expression was seen by day 7 ([Figure 2](#fig2){ref-type="fig"}B) with significant onset of SOX1 expression starting on day 4 ([Figure S2](#app2){ref-type="sec"}). We also asked whether pluripotent cells progress through a primitive ectoderm-like stage via an expression time course of OCT4, NANOG, and *Fgf-5* by RT-PCR and histological analysis ([Figures 2](#fig2){ref-type="fig"}C--2E and [S3](#app2){ref-type="sec"}). *Oct4* was detectable by PCR during the first 4 days, while *Fgf-5* expression appeared from day 3 to day 5 and *Sox1* rising from day 4 to day 6. Immunofluorescence showed that OCT4 was expressed in almost all cells up to day 3 (day 0, 926/979 cells; day 3, 326/354 cysts) ([Figures 2](#fig2){ref-type="fig"}D and [S3](#app2){ref-type="sec"}) while about 50% of the cysts downregulated NANOG by day 3 (114/216 cysts). *Fgf-5* expression peaked on day 3 (120/133 cysts) ([Figures 2](#fig2){ref-type="fig"}E and [S3](#app2){ref-type="sec"}). A small minority of aggregates that did not possess a lumen and is therefore not called a cyst continued to express OCT4 or NANOG uniformly at day 6 (16/254 OCT4^+^; 21/183 NANOG^+^), suggesting the perdurance of some undifferentiated ESCs. A small proportion of cysts coexpressed OCT4 and SOX1 (14/254) or NANOG and SOX1 (8/183) ([Figure 2](#fig2){ref-type="fig"}D). These results show that during neural cyst formation, ESCs turn on a marker of primitive ectoderm before differentiating into neurectoderm. The timing of the transitions correlated with murine development. mESCs correspond to E3.5 of mouse development. The onset of *Sox1* expression was detected around day 4 of in vitro differentiation, corresponding to stage E7.5, gastrulation.

Neuroepithelial Cysts Resemble Neural Plate Progenitors and Are Responsive to Morphogens {#sec2.3}
----------------------------------------------------------------------------------------

The neural plate initially consists of multipotent proliferating progenitors that largely express PAX3, PAX7, and MSX1+2 ([@bib5; @bib18; @bib22; @bib31]). Graded SHH signaling from the midline promotes ventral patterning leading to five distinct progenitor regions ([@bib6; @bib19; @bib27; @bib35]).

To investigate whether neuroepithelial cysts resemble the neural plate, we assessed dorsal markers. Whole-mount immunostainings revealed that the majority of 46C and R1 cysts uniformly coexpressed PAX3 and PAX7 ([Figure 3](#fig3){ref-type="fig"}A; data not shown). *Msx1* and the dorsal signaling molecules *Wnt1* and *Bmp7* were also expressed with some differences among the cell lines ([Figures 3](#fig3){ref-type="fig"}B, [S4](#app2){ref-type="sec"}A, and S4B). Exposure of cysts to 1 μM smoothened agonist (SAG) on day 3 for 24 hr yielded cysts that by day 7 had repressed *Msx1* ([Figure 3](#fig3){ref-type="fig"}C) but were positive for *Shh* ([Figure 3](#fig3){ref-type="fig"}F), FOXA2, and SHH at day 7 ([Figure 3](#fig3){ref-type="fig"}H, bottom; data not shown). These results indicate that neuroepithelial cysts can be ventralized to FP.

We did not observe any *Brachyury* expression by RT-PCR or in situ hybridization (ISH) ([Figure S4](#app2){ref-type="sec"}C), suggesting that SAG acted directly on the neuroepithelial cells to induce FP rather than via a notochord intermediate.

Posteriorization Potential of Neural Cysts {#sec2.4}
------------------------------------------

We next determined the default anterior/posterior (A/P) positional identity of the neural cysts. 46C and R1 cysts were *Otx2*^*+*^, *Gbx2*^*+*^, *HoxA2*^*+*^, and *Pax6*^*−*^ by RT-PCR ([Figures 4](#fig4){ref-type="fig"}A and [S5](#app2){ref-type="sec"}A) indicating an anterior identity. Diencephalon and spinal cord identities were excluded due to a lack of *Pax6* and of *HoxC4*, *HoxC5*, *HoxC6*, and *HoxC8* ([Figures 4](#fig4){ref-type="fig"}A and [S5](#app2){ref-type="sec"}A). ISHs (46C and IB10) and immunofluorescence (46C, R1, and IB10) confirmed the PCR results. OTX2 mRNA and protein expression was observed in approximately 50% of 46C and IB10 cysts, whereas it was absent in R1 cysts ([Figures 4](#fig4){ref-type="fig"}B--4D, top; [Figures S5](#app2){ref-type="sec"}B and S5C). *Gbx2* expression was found in almost half of cysts, and a small minority of 46C and IB10 cysts showed *HoxC4* and *HoxC6* expression ([Figure 4](#fig4){ref-type="fig"}B, top; [Figure S5](#app2){ref-type="sec"}B). No HOXB4 protein expression was observed ([Figure 4](#fig4){ref-type="fig"}D, top; [Figure S5](#app2){ref-type="sec"}D, top). Coimmunostaining for OTX2 and EN1, two markers that are coexpressed in the midbrain, showed that all OTX2^+^ cysts coexpressed EN1, suggesting midbrain identity ([Figure 4](#fig4){ref-type="fig"}C; [Figure S5](#app2){ref-type="sec"}C, top).

To posteriorize the cysts, we turned to RA ([@bib29; @bib44]). The addition of 250 nM RA for 18 hr at day 2 induced posteriorization to cervical levels in 93% of neural cysts, as evidenced by the induction of *HoxC4* and downregulation of *Otx2* ([Figures 4](#fig4){ref-type="fig"}A and 4B, bottom; [Figure S5](#app2){ref-type="sec"}A). *HoxC6* expression could be found in a minority of cysts ([Figures 4](#fig4){ref-type="fig"}A and 4B, bottom). These data were confirmed by immunostainings for OTX2 and HOXB4 on day 7 ([Figure 4](#fig4){ref-type="fig"}D, bottom; [Figure S5](#app2){ref-type="sec"}D, bottom).

Global RA Application Also Induces SHH^+^ FP and Consequent D/V Patterning {#sec2.5}
--------------------------------------------------------------------------

We next sought to achieve DV patterning in posteriorized cervical cysts via induction of a localized FP. Remarkably, patterning including localized FP formation occurred spontaneously after RA induced posteriorization in 44.1% ± 9.8% of R1 cysts and in 43.7% ± 17% of 46C cysts ([Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}A). The great majority of self-patterned cysts only possessed one FP (203/207), while 4 cysts out of 207 had two FPs. RA induced SHH^+^ FPs lacked SOX1 ([Figure 5](#fig5){ref-type="fig"}A), displayed basally located nuclei (arrow), and coexpressed FOXA2 and ARX with FOXA2 expanding a bit further laterally as seen in the in vivo FP ([Figures 5](#fig5){ref-type="fig"}C and [S6](#app2){ref-type="sec"}B). ARX, a late FP marker, was found starting from day 7.

To examine whether FP formation had occurred via RA-induced mesodermal differentiation, we checked patterned cysts via RT-PCR and ISH for *Brachyury* and found no detectable *Brachyury* signal, suggesting that FP induction via RA stimulation is a direct event on neural cells (data not shown).

We next examined the distribution of ventral cell types near the induced FP. The MN marker OLIG2 was expressed close but not adjacent to the SHH^+^ zone ([Figures 5](#fig5){ref-type="fig"}C and 5D), suggesting that intervening regions had p3 identity. ISL1/2, the differentiation marker for MNs, was also found close to the FP distributed laterally ([Figure 5](#fig5){ref-type="fig"}E). Neurons grew out of the neuroepithelial cysts on the basolateral sides, as evidenced by βIII-TUBULIN staining ([Figure 5](#fig5){ref-type="fig"}E). The interneuron marker LIM1+2 ([Figure 5](#fig5){ref-type="fig"}D) was found further from the SHH zone than OLIG2. The dorsal markers PAX3 and BRN3a could both be detected in some of the self-patterned cysts opposite the FP ([Figure 5](#fig5){ref-type="fig"}F). To investigate BMP signaling, we immunostained patterned cysts for activated SMADs (pSMAD) and observed nuclear signals opposite to the FP ([Figure S6](#app2){ref-type="sec"}C).

Interestingly, cysts that expressed localized SHH and PAX3 (SHH^+^/PAX3^+^) were on average larger (139.3 ± 35 μm) than unpatterned (PAX3^+^, 97 ± 28 μm) or partially patterned (SHH^+^, 124.9 ± 38.2 μm) cysts ([Figure S6](#app2){ref-type="sec"}D), suggesting that the full spectrum of DV cell types could only be achieved by large cysts in which cells opposite the FP escaped its signaling. Smaller FP-containing cysts showed a less complete spectrum of dorsal cell types, PAX3^−^ and BRN3a^−^, but OLIG2^+^ and LIM1+2^+^, suggesting that ventralizing SHH signals had dominated.

Since RA is added early (day 2) in our protocol, we strove to define the earliest time point in which a hallmark of patterning could be observed. We stained day 3 to day 7 cysts for OLIG2, SHH, and FOXA2 and called a cyst "patterned" when it expressed OLIG2 and one FP marker at the same time. On day 3, 6% ± 10.4% and on day 4, 42.2% ± 14.9% of R1 cysts expressed FOXA2 ([Figure 6](#fig6){ref-type="fig"}B) but did not yet express any OLIG2 or SHH. On day 5, 17.5% ± 9% of the cysts were FOXA2^+^ but still OLIG2^−^ and SHH^−^, and 17.6% ± 6.0% of all cysts expressed OLIG2 as well as FOXA2 and SHH and thus were patterned. Only a small population of cysts expressed FOXA2 and SHH but not yet OLIG2. On days 6 and 7, the FOXA2 single-positive population as well as the FOXA2^+^,SHH^+^,OLIG2^−^ population decreased further whereas the FOXA2^+^,SHH^+^,OLIG2^+^ triple-positive population increased up to 37.7% ± 9%. We conclude that RA stimulation first induces FOXA2 and then SHH expression. Secretion of SHH from the induced source then signals the formation of other ventral cell types like OLIG2^+^ cells nearby.

To directly address whether FP induction can be inhibited, we blocked SHH signaling using cyclopamine that was kept in the culture media either for the duration of the RA pulse (18 hr) or for a total of 72 or 120 hr. The cells were fixed at day 7 and analyzed for FOXA2 and SHH expression. Administration of cyclopamine for 18 hr showed almost no effect on blocking FP formation. Prolonging the cyclopamine treatment to 72 hr significantly reduced the number of cysts harboring a FP ([Figure 6](#fig6){ref-type="fig"}C). Only a minority of cysts expressed FOXA2 and SHH when the treatment was prolonged to 120 hr. These results suggest that SHH signaling is necessary in order to induce full FP formation in cysts.

To further show the relevance of SHH signaling on cyst patterning, we incubated the RA-treated cysts with 1 μM SAG on day 3 and found a strong bias to ventral fates. A 9 hr SAG pulse gave rise to SOX1::GFP^+^ cysts with low levels of FOXA2, strong NKX6.1, as well as NKX2.2 and ISL1/2 but no LIM1+2 ([Figure S7](#app2){ref-type="sec"}A). Lowering SAG to 100 nM for 8 hr yielded a mixture of PAX6^+^, EVX1/2^+^ cysts and OLIG2^+^, LIM1+2^+^, ISL1/2^+^ cysts, reflecting more dorsal/lateral fates ([Figure S7](#app2){ref-type="sec"}B).

Defined 3D Matrices Also Permit RA-Induced Self-Patterning {#sec2.6}
----------------------------------------------------------

Matrigel is a complex, undefined matrix, so we determined whether cyst formation and RA induced self-patterning also occurred in simpler matrix conditions. We grew R1 cysts in laminin/entactin gels and also found that cysts were uniformly PAX3^+^ and did not express SHH ([Figure 7](#fig7){ref-type="fig"}A). After an RA pulse, 46.8% ± 7.6% of R1 cysts expressed SHH, and we found patterned cysts that expressed PAX3 and BRN3a, as well as OLIG2, and LIM1+2 closer to the SHH^+^ domain ([Figures 7](#fig7){ref-type="fig"}B--7D). To test whether ECM proteins were necessary at all, we employed pure PEG gels and found patterned cysts at a lower frequency compared with Matrigel conditions ([Figure 7](#fig7){ref-type="fig"}E). Complete DV patterned cysts based on PAX3 and SHH expression were also observed ([Figures 7](#fig7){ref-type="fig"}F and 7G). These results show that patterning induced by RA is neither dependent on ECM proteins nor on growth factors present in Matrigel.

Discussion {#sec3}
==========

Here we show that single-cell suspensions of mouse ESCs grown in neural differentiation media and 3D matrices form spherical/ellipsoid neuroepithelia that harbor a single lumen, have clear apical/basolateral polarity, and show pseudostratification and interkinetic nuclear migration, structures that we call neuroepithelial cysts. In vivo, the neural tube forms from a planar neuroepithelial sheet that folds together to generate the lumen-containing tube. It is interesting that in vitro, as the ESCs divide and progress along the neural lineage, they generate a lumen at quite early stages corresponding to primitive ectoderm, presumably due to their E-CADHERIN-based epithelial character. This mode of lumen formation may resemble the tendency of inner cell mass cells to generate in vivo rosettes ([@bib4]). Once lumen formation is initiated, it is maintained as the cells transit into an N-CADHERIN^+^,SOX1^+^ neuroepithelial state. Upon prolonged culturing, cells within the cysts undergo neural differentiation as judged by expression of transcription factors associated with neuronal precursors, as well as neuronal differentiation markers. The spatial location of the neuronal differentiation occurred at the basal side of the neuroepithelium.

In this system, exogenous extracellular matrix components may have enhanced cyst-forming ability but were not absolutely necessary for lumen-containing neuroepithelial cyst formation, as they also formed in pure PEG gels. Here we implemented relatively high cell densities in the starting culture conditions leading to the possibility of paracrine effects on ECM secretion that might promote cyst formation. Separate work examining cyst formation under lower density conditions in defined, engineered matrices coupled to proteinaceous ECM components and combined with the soluble factor screening revealed a requirement for paracrine factors and a stronger dependence on matrix components for efficient cyst formation, as well as a stiffness optimum (A.R., unpublished data). Such work will help to define the minimum conditions required to generate neural cysts in the complete isolation from other cells.

Interestingly, we observed localized FP formation after global application of RA and subsequent elaboration of DV progenitor cell domains. Previous work extensively characterizing RA effects on embryoid bodies had shown the induction of SHH by RA administration and consequently the ventralization of neural tube markers ([@bib29]). In those pioneering studies, since the embryoid bodies contained multiple other cell types including mesoderm and the analysis was performed by RT-PCR, it was not clear if the RA was inducing SHH expression in notochord-like cells and/or whether it had induced a FP. The spatial arrangement of the FP and other neural markers could not be analyzed since the immunostaining was performed on replated cells, whereas here we analyze the 3D cysts in situ by confocal microscopy. Since we produce cysts by direct culturing of single ESCs in Matrigel plus neural induction media without serum, we do not find evidence for mesoderm. Through immunostaining, we observed the formation of SHH^+^ARX^+^ region within the neuroepithelial cells themselves. These data indicate that our cysts induce a FP that might be directly induced by RA in the absence of induction from a notochord-like structure. We then observe the formation of ventral progenitor domains with a very similar spatial arrangement as that found in the in vivo neural tube ([@bib3]).

This observation leads to two questions: first, is RA an endogenous contributor to FP induction, and second, how does global application lead to the formation of a local FP? The induction of a focal SHH signaling center by RA has been observed in multiple embryological contexts, including chicken wing ([@bib41]), zebrafish pectoral fin, and mouse limb ([@bib16; @bib26]), incisor ([@bib20]), lung ([@bib8; @bib9]), pancreas ([@bib24]), and prostate ([@bib42]). While SHH from the notochord is required for SHH induction in the neural tube, other molecules are likely to be involved in FP induction. For example, it is not fully explained why the contact of the notochord with the presumptive FP is necessary for induction. Indeed, RA was examined as one potential candidate to cooperate with SHH to induce FP but did not induce SHH in rat neural plate tissue ([@bib32]). Chick neural plate explants treated with 9-*cis*-RA or RAR agonist did not induce SHH but rather differentiated into NeuroM^+^ cells ([@bib10]). However, in these studies, the timing of RA addition may have been too late as cells were already specified to neural fate. In our system, RA was added at day 2 corresponding to gastrulation stage E5.5. Support for an endogenous role for RA in FP induction comes from experiments with *RALDH2*^*−/−*^ mice. Although the mRNA transcript for *Shh* can be detected at 14--15 somite stage and E9.5, no SHH protein was observed ([@bib34]). Furthermore Henson's node, notochord, and FP secrete RA ([@bib43]). Since the nature of the earliest events affecting DV patterning of the neural tube remain obscure, it remains possible that RA signaling during gastrulation/early neurulation contributes to neural tube DV patterning ([@bib36]). In vivo, RA may act as a permissive factor that makes the neural plate cells competent to initiate FP formation when the final SHH trigger occurs.

The in vitro conditions for RA-induced FP induction required high concentrations of RA, pointing possibly to an epiphenomenon that jump starts a self-enhancing activator/inhibitor signaling system, leading to localized FP formation. Both the *FoxA2* gene, a transcription factor required for SHH expression, and the *Shh* gene encoding SHH, which can induce FOXA2 expression, have RAR binding elements in their promoters ([@bib7; @bib29]). High levels of RA could access these promoters and initiate a positive feedback loop, enhancing expression of SHH. The SHH signaling pathway has a number of negative regulators, including PTC and GLI that could help to establish localized SHH expression ([@bib27]).

While the neuroepithelial cysts will be a valuable system for the study of patterning and other organizational aspects of neural development, they may ultimately prove valuable as a cell source for regenerative medicine approaches. In this regard, generation of spinal cord neuroepithelial cysts from human pluripotent stem cells would be of interest. [@bib46] showed that human ESCs could form neuroepithelial cysts under similar conditions, although the default A/P identity of the cysts was in the eyefield. An important future endeavor will be to define whether RA can simultaneously posteriorize and induce FP in human ESC-derived cysts, as they do in the mouse system.

Experimental Procedures {#sec4}
=======================

Differentiation of mESCs in the Neuroepithelial Cyst Model {#sec4.1}
----------------------------------------------------------

A mouse Sox1::GFP reporter ESC line (46C, gift of Konstantinos Anastasiadis, BIOTEC TU-Dresden, with permission of Austin Smith, University of Cambridge), R1 mESCs (gift of Ezio Bonifacio, CRTD), and IB10 mESCs (gift of Ronald Naumann, MPI-CBG) were cultured under standard conditions in complete medium consisting of Dulbecco's modified Eagle's medium (GIBCO) containing 15% fetal calf serum (PAA), 2 mM [l]{.smallcaps}-glutamine (GIBCO), nonessential amino acids (GIBCO), 1 mM sodium pyruvate, penicillin/streptomycin (Invitrogen), 0.1 mM β-mercaptoethanol (Sigma), and 1,000 U/ml leukemia inhibitory factor (LIF; Chemicon). The medium was changed daily. Every other day cells were passaged by trituration of the colonies after trypsinization. For cyst preparations, single ESCs were washed twice with PBS and resuspended in neural induction medium N2B27 ([@bib33]). A total of 50,000 single ESCs resuspended in 10 μl N2B27 were embedded in 150 μl Matrigel and distributed equally over five 3.5 cm^2^ glass bottom dishes (MatTek). After gelling at 37°C for 15 min, the embedded cells were cultured in N2B27. In separate experiments, laminin/entactin gels (Corning), diluted with chilled N2B27 to 10 mg/ml, or PEG gels (see below) were used instead of Matrigel. The laminin/entactin matrix was allowed to gel for 30 min at 37°C. For posteriorization, 250 nM all-*trans* RA (Sigma) was added to the differentiation medium on day 2 for 18 hr. For ventralization to FP, 1 μM smoothened agonist SAG (Calbiochem) was added on day 3 for 24 hr. To inhibit FP formation, 1 μM or 5 μM cyclopamine (Tocris) was added on day 2 for 18, 72, or 120 hr to the culture medium. The medium was replaced with fresh cyclopamine after the RA pulse (day 3) and on day 5 of cyst growth.

Hydrogel Precursor Synthesis {#sec4.2}
----------------------------

Forty kDa, 8-arm PEG vinylsulfone (PEG-VS) (NOF) was functionalized with FXIIIa-peptide substrates via Michael-type addition. A glutamine-containing peptide (NQEQVSPL-ERCG-NH~2~) and a lysine-containing peptide with an MMP-insensitive sequence (AcFKGG-*GDQGIAGF*-ERCG-NH~2~) were used to obtain glutamine-PEG precursor (Q-PEG) and lysine-PEG precursor (A-PEG) polymers. Functionalization and characterization of these precursors were performed as described elsewhere ([@bib12]).

FXIII Activation {#sec4.3}
----------------

Factor XIII (Fibrogammin P, CSL Behring) was reconstituted in water from lyophilized powder to a concentration of 200 U/ml; 1 ml of factor XIIIa was activated with 100 μl of thrombin (20 U/ml; Sigma-Aldrich) for 30 min at 37°C and stored at −80°C for further use.

Hydrogel Preparation {#sec4.4}
--------------------

Precursor solutions to give hydrogels with a final dry mass content of 1.5% w/v were prepared by stoichiometrically balanced solutions of Q-PEG and A-PEG in Tris-Buffer (50 mM final concentration \[pH 7.6\]) containing 50 mM CaCl~2~. A total of 50,000 ESCs (5 × 10^6^ cells/ml) were added to a final gel volume of 150 μl. Crosslinking was initiated by 10 U/ml thrombin-activated factor XIIIa and vigorous mixing. The cell-gel solution was distributed equally over five 35 mm glass bottom culture dishes (MatTek) and gelled for 25 min at 37°C, and the embedded cells were cultured in N2B27 identical to Matrigel culture.

Immunocytochemistry {#sec4.5}
-------------------

Whole-mount preparations were fixed in 4% paraformaldehyde (Sigma Aldrich) for 20 min at room temperature. After quenching (1 × PBS, 200 mM glycine, 0.3% Triton X-100) and antigen retrieval (70°C, 25 min, 1 × citrate buffer; DAKO), the tissue was blocked for 1 hr at room temperature (1 × PBS, 0.5% BSA, 0.3% Triton X-100). Immunostaining was performed in blocking buffer at 4°C overnight. The list of primary and secondary antibodies can be found in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

For 5-ethynyl-2′-deoxyuridine (EdU) incorporation, day 5 neural cysts were incubated with EdU for 1 hr and fixed thereafter. EdU was detected using the Click-iT EdU Alexa Fluor 647 Imaging Kit (Invitrogen).

For the pSMAD, SHH double staining, cysts were first stained for pSMAD, and after several washes, SHH staining was performed on top. Negative controls were performed using either no primary antibody or lambda protein phosphatase (New England Biolabs) treatment.

Fluorescent images were collected using a Leica TCS SPE or Zeiss LSM 510 confocal microscope. Acquisition was 2-fold oversampled, and pictures blurred afterward.

Time-Lapse Analysis {#sec4.6}
-------------------

Cyst formation was imaged through the acquisition of z stacks every 2 hr using MetaMorph Software using a motorized inverted Zeiss microscope that was temperature and CO~2~ controlled. SOX1::GFP cyst tracking from day 2 to day 6 was performed using a Zeiss Axio Observer system. Six positions per dish were saved and reimaged on a daily routine.

RT-PCR {#sec4.7}
------

Total RNA was extracted from untreated or posteriorized mESC derived cysts using an RNeasy kit (QIAGEN), treated with RNase-free DNaseI (Invitrogen), and reverse transcribed with SuperScript II (Invitrogen). The synthesized cDNA was amplified with gene-specific primers. The primers used are available in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

ISH on Cyst Cryosections {#sec4.8}
------------------------

ISHs were carried out on 12 μm cryosections as previously described ([@bib38; @bib46]). Sense and antisense probes of *Otx2*, *Gbx2*, *HoxC4*, *HoxC6*, *Shh*, *Bmp7*, *Fgf5*, and *Msx1* for ISHs were obtained by PCR from murine genomic DNA. An antisense probe for *Brachyury* was obtained by PCR from murine E13 cDNA, and the antisense probe for *Wnt1* was obtained by PCR from the clone D030017M24. The primers used for probe generation as well as a detailed protocol are available in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Electron Microscopy {#sec4.9}
-------------------

Electron microscopy analysis was performed as described ([@bib11]). A more detailed description can be found in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Statistical Analysis {#sec4.10}
--------------------

Values are expressed as mean ± SD. All experiments were repeated at least three times except the characterization of IB10 (n = 2). For quantification of immunostained cysts, 100 cysts were manually counted per dish in random fields from confocal microscope images based on Hoechst-stained nuclei and their morphological appearance to determine the total number of cysts. For quantifications of unpatterned cysts, we counted a cyst as positive for a specific marker when this marker was expressed in about 50% of the cells. In self-patterned cysts, we counted cysts as patterned and positive for a specific marker as soon as we could detect a few positive cells. For quantification of ISHs, 200 to 500 cysts were counted manually.
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![Characterization of Neural Cysts Derived from mESCs\
(A--G) Scheme of the generation of neural cysts. Within 5 days neuroepithelial cysts form that express SOX1::GFP and possess a single lumen (B). Day 6 neural cysts are apicobasally polarized, as shown by the luminally expression of PROMININ-1 (C and G) and the tight junction marker ZO-1 (D). The neural stem cell markers NESTIN (E) and MUSASHI (F) are also being expressed. To show that SOX1::GFP cysts are 100% neural in character, we also stained for the protein SOX1 (white nuclei, G).\
(H) Cells in a cyst undergo interkinetic nuclear migration, as evidenced by staining for phosphorylated histone 3 (pH3) and the thymidine analog EdU. Cells undergoing division are located at the apical side (pH3^+^), whereas cells in S phase which are EdU^+^ are located at the basal side.\
(I and J) Electron microscopic analysis of early neuroepithelial cysts. Cysts possess tight junctions (arrows), have large apical membrane surfaces with microvilli and primary cilia (J), and shed midbodies (stars) into the lumen.\
(K) Quantification of SOX1::GFP^+^ cysts at day 5.5 and day 7 of differentiation. Data are represented as mean ± SD (n = 3 independent experiments with 100 cysts counted per experiment).\
(L--N) Around day 7 to day 8, postmitotic neurons start to grow out basally, as evidenced by NeuN (L) and βIII-TUBULIN (L and M) as well as MAP2a (N).\
Nuclei were counterstained with Hoechst. All data shown were derived with the SOX1::GFP reporter cell line 46C. All immunofluorescence panels (C--H and L--N) represent confocal images of 3D cysts. Scale bars represent 20 μm (C--H and L--N), 2 μm (I), and 0.5 μm (J). See also [Figure S1](#app2){ref-type="sec"}.](gr1){#fig1}

![Neural Cysts Can Develop Clonally and Show Progressive Expression of Early Developmental Markers\
(A) Phase-contrast images from [Movie S1](#mmc2){ref-type="supplementary-material"} showing the clonal growth of a neuroepithelial cyst over a time course of 5 days (20×). The imaged cyst was fixed and stained for PROMININ-1 (red) showing that the imaged cyst possesses a lumen.\
(B) E-CADHERIN and N-CADHERIN expression during a time course. Early cysts express exclusively E-CADHERIN (days 2--4). By day 7, many cysts express SOX-1 and concomitantly show high N-CADHERIN and low E-CADHERIN expression. Nuclei were counterstained with Hoechst. Scale bars represent 20 μm.\
(C--E) RT-PCR analysis for markers that are expressed during early development. From day 0 to day 3, cells exclusively express the ESC marker *Oct4*. Then *Fgf5* starts being expressed, a marker for primitive ectoderm. *Fgf5* becomes downregulated as the neuroectodermal marker *Sox1* starts being expressed. Using immunofluorescence, the progression of developmental markers was quantified in more detail (D; see [Figure S3](#app2){ref-type="sec"}). OCT4 and NANOG were expressed in almost all cells on day 0 after seeding. OCT4 expression persisted up to day 3, whereas NANOG expression declined. On day 6, the majority of the structures analyzed were SOX1^+^. *Fgf5* expression was analyzed by ISH and peaked on day 3 but was absent from all structures analyzed on day 0 and day 6 (E). Data shown in (D) and (E) represent counts from one out of three representative experiments in which around 1,000 cells on day 0 and 200 cysts on day 3 and day 6 were counted.\
See also [Figures S2](#app2){ref-type="sec"} and [S3](#app2){ref-type="sec"} and [Movie S1](#mmc2){ref-type="supplementary-material"}.](gr2){#fig2}

![Default Dorsal Identity of Neural Cysts and Their Ventralizability by SHH Signaling\
(A) Immunostained neuroepithelial 46C cysts were PAX7^+^ (white) and PAX3^+^ (red) showing their dorsal identity. PAX3 expression is shown in black and white in the single stained panel but in red in the merge. SOX1::GFP was not imaged.\
(B) Characterization of the DV identity of neuroepithelial cysts by ISH using an *Msx1* probe showing that untreated 46C cysts are *Msx1*^+^.\
(C) After ventralization with 1 μM SAG, cysts do not express *Msx1* anymore.\
(D) As corresponding positive control, we used a cross-section of a murine E12.5 spinal cord that shows labeling only at the roof plate.\
(E and F) ISH for *shh* to show that untreated 46C cysts are negative for *shh* but express *shh* upon stimulation with 1μM SAG for 24 hr on day 3 (F).\
(G) As a corresponding positive control to show the specificity of our probe, we used a cross-section of a murine E9.5 spinal cord that shows labeling only in the FP.\
(H) Untreated 46C control cysts express SOX1::GFP and are FOXA2^−^ as well as SHH^−^ (top). Addition of 1 μM SAG on day 3 for 24 hr leads to the induction of FOXA2 and SHH while SOX1::GFP gets downregulated, indicating that neural cysts are able to differentiate into FP (bottom).\
All nuclei in (A) and (H) were counterstained with Hoechst. Scale bars represent 50 μm (A--H). See also [Figure S4](#app2){ref-type="sec"}.](gr3){#fig3}

![A/P Positional Identity of Neural Cysts and Posteriorization to the Cervical Spinal Cord\
(A) RT-PCR analyses for markers of A/P identity using untreated cysts (−RA) as well as posteriorized cysts (+RA) on day 7 of differentiation. As positive control, murine genomic DNA was used.\
(B) ISH on cryosectioned cysts to examine localization of *Otx2*, *Gbx2*, *HoxC4* and *HoxC6* mRNAs (top). Subsets of day 7 cysts express *Otx2* or *Gbx2*. Almost all cysts were *HoxC4*^−^ and *HoxC6*^−^. After treating cysts with 250 nM RA for 18 hr, *Otx2* and *Gbx2* are downregulated. *HoxC4* is upregulated in almost all RA treated neural cysts, whereas *HoxC6* is only expressed in a minority of RA treated cysts (bottom).\
(C) Immunofluorescence analysis of untreated cysts immunostained for OTX2 (red) and EN1 (white). SOX1::GFP^low/−^ neural cysts coexpress OTX2 and EN1. SOX1-GFP^+^ cysts are negative for both markers.\
(D) Immunofluorescence analysis of untreated cysts immunostained for OTX2 (red) and HOXB4 (white) showing that all control cysts are HOXB4^−^ (top). After posteriorization with 250 nM RA for 18 hr on day 2, cysts uniformly express HOXB4, whereas OTX2 is downregulated (bottom). All nuclei in (C) and (D) were counterstained with Hoechst.\
Scale bars represent 50 μm (B--D). See also [Figure S5](#app2){ref-type="sec"}.](gr4){#fig4}

![Self-Organized DV Patterning in Posteriorized Neuroepithelial Cysts\
(A) Self-patterned neuroepithelial cysts derived from 46C ESCs show that the FP region which is SHH^+^ (red) is SOX1::GFP^−^ and has basally localized nuclei (arrow).\
(B) Scheme of the experimental setup.\
(C) The FP region coexpresses SHH (green) and FOXA2 (white). Close to the FP region but not directly adjacent to it the progenitor marker OLIG2 (red) stains on both sides, corresponding to the pMN region.\
(D) The FP is marked by SHH expression (green) and the pMN region in white by OLIG2 expression. Further dorsal the interneuronal marker LIM1+2 (red) can be detected.\
(E) MNs identified by ISL1/2 stainings (white) can be detected close to the FP region stained with SHH (green) as well as dorsally. βIII-TUBULIN immunostaining (red) shows peripheral arrangement of differentiated neurons and their axons.\
(F) PAX3 (white) as a general dorsal marker and BRN3a (red) as a differentiation marker for dorsal interneurons were the furthest dorsal markers detected in self-patterned cysts. The FP region is marked in green by SHH.\
All nuclei were counterstained with Hoechst. Scale bars represent 50 μm. See also [Figure S6](#app2){ref-type="sec"}.](gr5){#fig5}

![Characterization of FP Induction by RA\
(A) Quantification of patterned cysts after stimulation with 100, 250, and 750 nM RA for 9, 18, and 24 hr. R1 cysts were analyzed on day 7 by immunostaining for SHH and OLIG2, and the percentage of cysts that were double positive was determined. Nine hours of incubation with 100 nM RA led to the formation of 7.2% ± 3.3% of self-patterned R1 cysts. This number increased significantly when the incubation period was prolonged to 18 hr (28.3% ± 7.6%) or 24 hr (30% ± 2%). The total fraction of patterned cervical cysts at 100 nM RA irrespective of incubation length never reached the same percentage as that obtained with 250 or 750 nM RA. Incubation with 250 or 750 nM RA led to similar results at any time point investigated (9 hr incubation, 25% ± 2.6% at 250 nM RA; 27.1% ± 5.4% at 750 nM RA; 18 hr or 24 hr incubation, around 40% of patterned cysts). These results indicate that optimal cyst patterning is dependent on a certain RA concentration and incubation time.\
(B) Characterization of the patterning onset in R1 cysts. Days 4--7 cysts were stained for OLIG2, FOXA2, and SHH after RA application on day 2, and the percentage of R1 cysts that was positive for any combination of the 3 markers, notably FOXA2^+^ SHH^−^ OLIG2^−^; FOXA2^+^ SHH^+^ OLIG2^−^ and FOXA2^+^ SHH^+^ OLIG2^+^, was determined.\
(C) Inhibition of FP induction through the administration of the SHH signaling inhibitor cyclopamine. On day 2, 1 and 5 μM cyclopamine was added together with RA for 18, 72, or 120 hr to growing cysts. On day 7, the percentage of patterned cysts based on the coexpression of FOXA2 and SHH was determined. FP induction was almost completely inhibited when cysts were grown for 120 hr in 1 or 5 μM cyclopamine.\
Data are represented as mean ± SD (n = 3 independent experiments with 100 cysts counted per experiment). See also [Figure S7](#app2){ref-type="sec"}.](gr6){#fig6}

![Defined 3D Matrices Also Permit RA-Induced Self-Patterning of Neuroepithelial Cysts\
(A--D) Cysts were grown in high concentration laminin/entactin gels. Untreated control cysts were uniformly PAX3^+^ (red, A) and patterned similar to cysts grown in Matrigel upon a RA pulse on day 2 as evidenced by immunofluorescence staining for SHH (green) and PAX3 (red, B), SHH (green) and BRN3a (red, C) as well as OLIG2 (green) and LIM1+2 (red, D).\
(E) Even in pure PEG gels, cysts grew and patterned after RA administration based on focal SHH expression, although to a lesser extent than in Matrigel as quantified.\
(F and G) Complete DV patterned cysts based on coexpression of PAX3 and SHH were also observed. Data are represented as mean ± SD for Matrigel (n = 3 independent experiments) and mean ± variance for PEG gels (n = 2 independent experiments) with 100 cysts counted per experiment. Nuclei were counterstained with Hoechst.\
Scale bars represent 50 μm (A--D) and 20 μm (G).](gr7){#fig7}
